Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3602215

O=C(N[C@@H]1CCNC1)c1cc2c(ccc3ccccc32)[nH]1.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 2/20 0.49
LMNA P02545 1/20 0.49
HSD17B10 Q99714 1/20 0.49
KDR P35968 1/20 0.46
MLLT1 Q03111 1/20 0.40
JAK2 O60674 1/20 0.40
PARP1 P09874 1/20 0.40
ACSS2 Q9NR19 1/20 0.40
HDAC4 P56524 2/20 0.39
SMYD3 Q9H7B4 1/20 0.39
GHSR Q92847 4/20 0.39
SLC2A1 P11166 1/20 0.39
CYP1A2 P05177 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
KHK P50053 1/20 0.37
HRH4 Q9H3N8 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
NPC1 O15118 1/20 0.37
NR1I2 O75469 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3601240 1.00 KDM4E (0.49) KDM4EALDH1A1LMNAHSD17B10KDR
SCHEMBL3602181 0.93 KDM4E (0.53) KDM4EALDH1A1LMNAHSD17B10KDR
SCHEMBL3598914 0.93 KDM4E (0.53) KDM4EALDH1A1LMNAHSD17B10KDR
SCHEMBL3598920 0.93 KDM4E (0.53) KDM4EALDH1A1LMNAHSD17B10KDR
Trifluoroacetic Acid SCHEMBL3606654 0.86 KDR (0.52) KDM4EALDH1A1LMNAKDRMLLT1
Trifluoroacetic Acid SCHEMBL3612189 0.84 ALB (0.47) KDRPARP1HDAC4SMYD3HDAC6
Trifluoroacetic Acid SCHEMBL3606633 0.84 ALB (0.47) KDRPARP1HDAC4SMYD3HDAC6
Trifluoroacetic Acid SCHEMBL3595860 0.83 CDK5 (0.46) KDRJAK2PARP1HDAC4SMYD3
Trifluoroacetic Acid SCHEMBL3605047 0.83 CDK5 (0.46) KDRJAK2PARP1HDAC4SMYD3
Trifluoroacetic Acid SCHEMBL3601873 0.80 DRD4 (0.46) KDRMLLT1PARP1HDAC4SMYD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035862-A1 NOVEL AZA-CYCLIC INDOLE-2-CARBOXAMIDES AND METHODS OF USE THEREOF ABBOTT LABORATORIES (US) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035862-A1 NOVEL AZA-CYCLIC INDOLE-2-CARBOXAMIDES AND METHODS OF USE THEREOF IDO2, IDO1, INMT KDM4E 963/4885ALDH1A1 513/4885LMNA 3287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.